GBS Stock Price, News & Analysis
Company Description
GBS (Nasdaq: GBS) is a publicly traded medical devices company in the Healthcare sector. The company has a market capitalization of $7.0M.
GBS stock has declined 77.8% over the past year.
This page provides a comprehensive overview of GBS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
GBS (GBS) stock. Over the past 12 months, the stock has lost 77.8%. At a market capitalization of $7.0M, GBS is classified as a micro-cap stock with approximately 14.9M shares outstanding.
Latest News
GBS has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, conferences. View all GBS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GBS Company Profile & Sector Positioning
GBS (GBS) operates in the Medical Devices industry within the broader Healthcare sector.
Investors comparing GBS often look at related companies in the same sector, including Xylo Technologies (XYLO), Autonomix Medical Inc (AMIX), Corvex Inc (MOVE), Strata Skin Sciences Inc (SSKN), and Solana Company (HSDT). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate GBS's relative position within its industry.